Holen Sie sich die Stockscreener-App
2.61
0.77%
0.02
Handel nachbörslich:
2.60
-0.010
-0.38%
Cognition Therapeutics Inc Aktie (CGTX) Neueste Nachrichten
Visualizing Cognition Therapeutics Inc. stock with heatmapsPortfolio Growth Summary & Community Supported Trade Ideas - Newser
Cognition Therapeutics Regains Nasdaq Compliance - MSN
Cognition Therapeutics Inc. stock retracement – recovery analysisInsider Buying & Daily Stock Trend Watchlist - Newser
Is Cognition Therapeutics Inc. Forming a Bottom PatternMarket Sentiment Review & Weekly Momentum Stock Picks - beatles.ru
Chart overlay techniques for tracking Cognition Therapeutics Inc.2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Cognition Therapeutics Inc. stock prediction for this weekTreasury Yields & Daily Chart Pattern Signal Reports - Newser
Tick level data insight on Cognition Therapeutics Inc. volatilityMarket Trend Report & Fast Moving Stock Trade Plans - Newser
Can Cognition Therapeutics Inc. keep up with sector leaders2025 Bull vs Bear & Free Community Consensus Stock Picks - خودرو بانک
Neurology biopharmas rebound on trial catalysts and Q2 gains - BioWorld MedTech
What moving averages say about Cognition Therapeutics Inc.2025 Retail Activity & High Yield Stock Recommendations - Newser
Is Cognition Therapeutics Inc. a stock for growth or value investors2025 Price Targets & Low Drawdown Trading Strategies - خودرو بانک
Backtesting results for Cognition Therapeutics Inc. trading strategiesMarket Risk Report & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-05 00:35:53 - Newser
Published on: 2025-09-05 00:14:17 - Newser
Real time pattern detection on Cognition Therapeutics Inc. stockRisk Management & Advanced Technical Signal Analysis - Newser
Support Zone Holds Steady for Cognition Therapeutics Inc. After DipMarket Weekly Review & Weekly High Conviction Ideas - Newser
Multi asset correlation models including Cognition Therapeutics Inc.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser
Cognition Therapeutics Inc. stock trend forecastTrade Entry Summary & Breakout Confirmation Trade Signals - Newser
Top chart patterns to watch in Cognition Therapeutics Inc.Weekly Trend Report & Safe Capital Growth Plans - Newser
How to manage a losing position in Cognition Therapeutics Inc.Earnings Overview Report & Low Risk High Win Rate Picks - Newser
Can Cognition Therapeutics Inc. recover in the next quarter2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
How sentiment analysis helps forecast Cognition Therapeutics Inc.Quarterly Growth Report & Daily Entry Point Alerts - Newser
Real time scanner hits for Cognition Therapeutics Inc. explainedTreasury Yields & Community Verified Swing Trade Signals - Newser
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone By Investing.com - Investing.com South Africa
Cognition Therapeutics closes $30 million registered direct offering By Investing.com - Investing.com Australia
Does Cognition Therapeutics Inc. have pricing power2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - khodrobank.com
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone - Investing.com
Trend analysis for Cognition Therapeutics Inc. this weekPortfolio Update Summary & AI Powered Trade Plan Recommendations - Newser
Cognition Therapeutics, Inc. Achieves 75% Enrollment in Phase 2 START Study for Early Alzheimer’s Disease Treatment - Quiver Quantitative
Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target - GlobeNewswire
540-Patient Alzheimer's Trial: Cognition's Once-Daily Oral Drug Zervimesine Reaches Major Milestone - Stock Titan
What’s next for Cognition Therapeutics Inc. stock price2025 Performance Recap & Growth-Oriented Investment Plans - Newser
MACD Cross Could Confirm Trend in Cognition Therapeutics Inc.Weekly Market Summary & AI Enhanced Trading Alerts - beatles.ru
Cognition Therapeutics shares fall 1.23% premarket after closing a $30 million registered direct offering. - AInvest
How to integrate Cognition Therapeutics Inc. into portfolio analysis toolsJuly 2025 Decliners & Advanced Technical Analysis Signals - Newser
Is Cognition Therapeutics Inc. still worth holding after the dipGold Moves & Free Safe Capital Growth Stock Tips - Newser
Cognition Therapeutics Inc. stock trend outlook and recovery pathTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
Will Cognition Therapeutics Inc. stock go up soonJuly 2025 Momentum & Short-Term Swing Trade Alerts - Newser
How to build a custom watchlist for Cognition Therapeutics Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
What to expect from Cognition Therapeutics Inc. in the next 30 daysWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - Newser
Automated trading signals detected on Cognition Therapeutics Inc.Take Profit & Expert Curated Trade Setup Alerts - Newser
Is Cognition Therapeutics Inc. trading at a discountJuly 2025 Trends & Smart Money Movement Alerts - خودرو بانک
Cognition Therapeutics Closes $30 Million Direct Offering - MarketScreener
Cognition Therapeutics closes $30 million registered direct offering - Investing.com
Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812) - GlobeNewswire
$30 Million Funding: Cognition Therapeutics Advances Breakthrough Neurodegenerative Drug to Phase 3 - Stock Titan
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):